Assessing equivalence: An alternative to the use of difference tests for measuring disparities in vaccination coverage

被引:75
作者
Barker, LE [1 ]
Luman, ET [1 ]
McCauley, MM [1 ]
Chu, SY [1 ]
机构
[1] Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA
关键词
epidemiologic methods; ethnic groups; hypothesis testing; immunization; statistics; vaccination; vaccines;
D O I
10.1093/aje/kwf149
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
Eliminating health disparities in vaccination coverage among various groups is a cornerstone of public health policy. However, the statistical tests traditionally used cannot prove that a state of no difference between groups exists. Instead of asking, "Has a disparity-or difference-in immunization coverage among population groups been eliminated?," one can ask, "Has practical equivalence been achieved?" A method called equivalence testing can show that the difference between groups is smaller than a tolerably small amount. This paper demonstrates the method and introduces public health considerations that have an impact on defining tolerable levels of difference. Using data from the 2000 National Immunization Survey, the authors tested for statistically significant differences in rates of vaccination coverage between Whites and members of other racial/ethnic groups and for equivalencies among Whites and these same groups. For some minority groups and some vaccines, coverage was statistically significantly lower than was seen among Whites; however, for some of these groups and vaccines, equivalence testing revealed practical equivalence. To use equivalence testing to assess whether a disparity remains a threat to public health, researchers must understand when to use the method, how to establish assumptions about tolerably small differences, and how to interpret the test results.
引用
收藏
页码:1056 / 1061
页数:6
相关论文
共 15 条
[1]
THE RESURGENCE OF MEASLES IN THE UNITED-STATES, 1989-1990 [J].
ATKINSON, WL ;
ORENSTEIN, WA ;
KRUGMAN, S .
ANNUAL REVIEW OF MEDICINE, 1992, 43 :451-463
[2]
Equivalence testing for binomial random variables: Which test to use? [J].
Barker, L ;
Rolka, H ;
Rolka, D ;
Brown, C .
AMERICAN STATISTICIAN, 2001, 55 (04) :279-287
[3]
PROVING THE NULL HYPOTHESIS IN CLINICAL-TRIALS [J].
BLACKWELDER, WC .
CONTROLLED CLINICAL TRIALS, 1982, 3 (04) :345-353
[4]
Blackwelder WC, 1998, ENCY BIOSTATISTICS
[5]
TEST STATISTICS AND SAMPLE-SIZE FORMULAS FOR COMPARATIVE BINOMIAL TRIALS WITH NULL HYPOTHESIS OF NONZERO RISK DIFFERENCE OR NON-UNITY RELATIVE RISK [J].
FARRINGTON, CP ;
MANNING, G .
STATISTICS IN MEDICINE, 1990, 9 (12) :1447-1454
[6]
HUH MH, 1994, J KOREAN STAT SOC, V23, P199
[7]
Luman ET, 2001, AM J PREV MED, V20, P88
[8]
A COMPARISON OF THE 2 ONE-SIDED TESTS PROCEDURE AND THE POWER APPROACH FOR ASSESSING THE EQUIVALENCE OF AVERAGE BIOAVAILABILITY [J].
SCHUIRMANN, DJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1987, 15 (06) :657-680
[9]
SHAH BV, 1997, SUDAAN VERSION 7 5 M
[10]
SHULKA R, 2000, TOXICOL CHEM, V19, P169